Patients with peripheral arterial disease (PAD) are more likely to develop sarcopenia through an altered inflammatory process, probably mediated by the deregulation of multiple cytokine-related factors, such as the elevation of IL-6, an IL-1 receptor antagonist, fibrinogen, and CRP. The gene discussed is IL6; the disease is peripheral arterial disease.